Experienced in Tetanus

Ursula Wiedermann

Vienna, AT 
Experienced in Tetanus
Vienna, AT 
OverviewLocationsClinical Research

Overview

Ursula Wiedermann practices in Vienna, Austria. Ms. Wiedermann is rated as an Experienced expert by MediFind in the treatment of Tetanus. Her top areas of expertise are Lung Metastases, Inclusion Conjunctivitis, Pertussis, Tetanus, and Splenectomy.

Her clinical research consists of co-authoring 83 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 3 articles in the study of Tetanus.

Gender
Female

Locations

Vienna, 1090, Austria

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Double Blinded, Randomized, Placebo Controlled, Dose Finding Trial to Evaluate the Optimal Dose of MV-ZIKA, a New Vaccine Against Zika Virus, in Regard to Immunogenicity, Safety, and Tolerability in Healthy Volunteers
Double Blinded, Randomized, Placebo Controlled, Dose Finding Trial to Evaluate the Optimal Dose of MV-ZIKA, a New Vaccine Against Zika Virus, in Regard to Immunogenicity, Safety, and Tolerability in Healthy Volunteers
Enrollment Status: Completed
Publish Date: August 18, 2022
Intervention Type: Biological, Other
Study Phase: Phase 1
TBE (Tick-borne Encephalitis ) Vaccination in Allergic Patients
TBE (Tick-borne Encephalitis ) Vaccination in Allergic Patients
Enrollment Status: Completed
Publish Date: October 25, 2019
Intervention Type: Biological
Study Phase: Phase 4
View 1 Less Clinical Trial

83 Total Publications

Antibody Responses Following Primary Immunization with the Recombinant Herpes Zoster Vaccine (Shingrix®) in VZV Seronegative Immunocompromised Adults.
Antibody Responses Following Primary Immunization with the Recombinant Herpes Zoster Vaccine (Shingrix®) in VZV Seronegative Immunocompromised Adults.
Journal: Vaccines
Published: June 12, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Wiedermann's expertise for a condition
ConditionClose
      View All 23 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile